Plasticell and Pierre Fabre Laboratories sign a partnership to identify natural stimulants of brown fat for treatment and prevention of obesity and diabetes
Plasticell, the biotechnology company specializing in stem cell differentiation, and Pierre Fabre, the 2nd largest independent French Pharmaceutical laboratory, today announced the signature of a collaboration agreement. The two companies will work together to discover plant-based products that enhance the metabolic function of brown adipose tissue (BAT) – also known as ‘brown fat’.
Plasticell will screen Pierre Fabre’s ‘Nature Open Library’ collection, one of the most important private plant libraries in the world numbering over 15000 phytochemical extracts, to identify natural products that increase the metabolic activity and other specific functions of BAT. In addition, Plasticell scientists may collaborate with Pierre Fabre botanists, phyto-chemists and regulatory specialists in the further development of products.
The collaboration will focus initially on screening extracts derived from the edible parts of plants, with the aim of developing functional foods or nutraceuticals.
This first collaboration with “Nature Open Library” in UK demonstrates that our initiative of open innovation can really promote new uses of plant extracts in many areas or domains, worldwide. We are confident and will do our best with Plasticell’s team to succeed in this project, said Laurent Audoly Director R&D Pierre Fabre Pharmaceuticals.
Obesity is the leading preventable cause of death, however only a handful of drugs exist to treat this condition - these have at best modest efficacy and potentially serious side effects. We aim to discover safe natural products that act on a newly discovered subtype of adipose tissue to increase the body’s energy expenditure, promoting weight loss without dieting and exercise, commented Dr Yen Choo, the Chairman of Plasticell.